Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Macugen Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
Growth during the historical period was driven by several key factors, including a higher incidence of age-related macular degeneration, more frequent diagnoses of diabetic eye conditions, a proliferation of specialized ophthalmology clinics, the early implementation of anti-VEGF treatments, and enhancements in retinal imaging technology.
The forecast period’s expansion is driven by a rising demand for extended-release eye medications, heightened investment in retinal research, greater uptake of customized ophthalmic therapies, the growth of eye care services catering to aging populations, and an increased priority on minimizing injection intervals. Key developments shaping this period include the growing application of targeted anti-VEGF treatments, the broader implementation of intravitreal injection methods, a stronger focus on therapies that preserve vision, the expansion of protocols for managing retinal diseases, and a more pronounced emphasis on sustaining long-term therapeutic outcomes.
Download A Free Sample Report For Comprehensive Market Insights:
Macugen Market Industry Drivers: What Is Driving Revenue Growth?
The increasing occurrence of age-related macular degeneration (AMD) is anticipated to fuel the expansion of the macugen market in the coming period. Age-related macular degeneration (AMD) is a progressive ocular disorder that impacts the macula, the central region of the retina responsible for sharp and detailed sight. This rising incidence of AMD stems from an aging worldwide population, extended life expectancy, and lifestyle influences like tobacco use, unhealthy eating habits, and chronic exposure to ultraviolet (UV) light. Macugen proves advantageous for AMD by blocking vascular endothelial growth factor (VEGF), decreasing abnormal blood vessel formation and fluid leakage in the retina, thereby aiding in vision preservation and decelerating disease advancement. As an example, in May 2023, an article from the National Center for Biotechnology Information, a US-based government agency under the National Institutes of Health, indicated that around 288 million individuals are forecasted to experience age-related macular degeneration (AMD) by 2040. Consequently, the growing prevalence of age-related macular degeneration (AMD) is propelling the macugen market’s growth.
Macugen Market Driver: Growing Focus On Eye Care And Its Impact On The Market
A heightened emphasis on eye care is expected to drive the macugen market’s growth in the future. Eye care encompasses practices and therapies designed to preserve or enhance vision and ocular health. This increased attention to eye care results from a higher incidence of eye conditions, aging demographics, and expanded awareness regarding the significance of visual health. Macugen contributes to eye care by effectively managing age-related macular degeneration (AMD) through the inhibition of abnormal blood vessel growth in the retina, which helps avert vision loss and boost visual sharpness. For instance, in November 2023, an article by Nature, a UK-based journal, noted that in August 2024, based on data from the Welsh Government, a United Kingdom governmental body, the number of sight tests funded by the NHS in Wales reached a new peak of over 841,000 in 2023-24, marking a 6.6% rise over 2022-23. Hence, the growing focus on eye care is propelling the macugen market forward.
Macugen Market Segment Analysis And Revenue Opportunities
The macugen market covered in this report is segmented –
1) By Indication: Wet AMD(Age-Related Macular Degeneration (AMD)), Diabetic Macular Edema
2) By Formulation: Intravitreal Injection, Extended-Release Formulations
3) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies
4) By End User: Adult Patients, Geriatric Patients
Macugen Market Growth Trends: What Is Influencing The Future Outlook?
A significant shift shaping the macugen market is the emergence of gene therapy. This approach works by inserting genetic material into a patient’s cells, with the goal of treating or preventing diseases—particularly age-related macular degeneration (AMD). As an example, in 2023, Regenxbio, a U.S.-based biotech firm, introduced RGX-314, a gene therapy product engineered to deliver a gene encoding an anti-VEGF protein directly into the eye. The intention behind this novel treatment is to offer enduring benefits, thereby minimizing the necessity for frequent injections. Among its distinctive characteristics is the possibility of requiring only a single dose, which can notably enhance patient adherence, along with its capacity to address AMD’s root causes rather than merely alleviating symptoms. Such progress positions these companies advantageously within the changing arena of ocular treatments.
Macugen Market Leading Players Shaping Industry Direction
Major companies operating in the macugen market are Bausch + Lomb Inc
Access The Complete Macugen Market Report:
Macugen Market Regional Analysis And Leading Geography
North America was the largest region in the macugen market in 2025. The regions covered in the macugen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model